Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Roles of Exosomes in Huntington’s Disease
Hanadi Ananbeh, Petr Vodička, Helena Kupcová Skalníková
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4085-4085
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Exosomes as New Generation Vehicles for Drug Delivery: Biomedical Applications and Future Perspectives
Amarjitsing Rajput, Akansh Varshney, Rashi Bajaj, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7289-7289
Open Access | Times Cited: 97
Cell Type-Specific Extracellular Vesicles and Their Impact on Health and Disease
Sohil Amin, Hamed Massoumi, Deepshikha Tewari, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2730-2730
Open Access | Times Cited: 19
Isolation and usage of exosomes in central nervous system diseases
Wenjing Wang, Hong Sun, Huijuan Duan, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 15
Neuroinflammation and neurodegeneration in Huntington’s disease: genetic hallmarks, role of metals and organophosphates
Omkar Kumar Kunwar, Shamsher Singh
Neurogenetics (2025) Vol. 26, Iss. 1
Closed Access | Times Cited: 2
Exosomal Proteins and Lipids as Potential Biomarkers for Lung Cancer Diagnosis, Prognosis, and Treatment
Ming-Tsung Hsu, Yu-Ke Wang, Yufeng Jane Tseng
Cancers (2022) Vol. 14, Iss. 3, pp. 732-732
Open Access | Times Cited: 60
Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases
Xiaohuan Xia, Yi Wang, Jialin Zheng
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 49
Exosomes in brain diseases: Pathogenesis and therapeutic targets
Qingying Si, Linlin Wu, Deshui Pang, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 31
Exosome-Based Macromolecular neurotherapeutic drug delivery approaches in overcoming the Blood-Brain barrier for treating brain disorders
Krishna Yadav, R. Vijayalakshmi, Kantrol Kumar Sahu, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2024) Vol. 199, pp. 114298-114298
Closed Access | Times Cited: 11
Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers
Mathieu Herman, Grace W. Randall, Julia L. Spiegel, et al.
Philosophical Transactions of the Royal Society B Biological Sciences (2024) Vol. 379, Iss. 1899
Open Access | Times Cited: 10
Metabolomic and Proteomic Profiling of Serum-Derived Extracellular Vesicles from Early-Stage Amyotrophic Lateral Sclerosis Patients
Yara Al Ojaimi, Nicolas Vallet, Audrey Dangoumau, et al.
Journal of Molecular Neuroscience (2025) Vol. 75, Iss. 1
Closed Access | Times Cited: 1
Huntingtin Co-Isolates with Small Extracellular Vesicles from Blood Plasma of TgHD and KI-HD Pig Models of Huntington’s Disease and Human Blood Plasma
Hanadi Ananbeh, Jaromir Novak, Štefan Juhás, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5598-5598
Open Access | Times Cited: 29
Small Extracellular Vesicles’ miRNAs: Biomarkers and Therapeutics for Neurodegenerative Diseases
Wei Qing Lim, Kie Hoon Michelle Luk, Kah Yee Lee, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1216-1216
Open Access | Times Cited: 17
Therapeutic advances in neural regeneration for Huntington's disease
Francesco D’Egidio, Vanessa Castelli, Giorgia Lombardozzi, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 9, pp. 1991-1997
Open Access | Times Cited: 16
Exosomes for neurodegenerative diseases: diagnosis and targeted therapy
Hui Tao, B. Gao
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 3050-3062
Closed Access | Times Cited: 6
Extracellular Vesicles: The Next Generation of Biomarkers and Treatment for Central Nervous System Diseases
Gabriele Zanirati, Paula Gabrielli dos Santos, Allan Marinho Alcará, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7371-7371
Open Access | Times Cited: 6
Plant Polyphenols for Aging Health: Implication from Their Autophagy Modulating Properties in Age-Associated Diseases
James Michael Brimson, Mani Iyer Prasanth, Dicson Sheeja Malar, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 10, pp. 982-982
Open Access | Times Cited: 33
Dual role of brain-derived extracellular vesicles in dementia-related neurodegenerative disorders: cargo of disease spreading signals and diagnostic-therapeutic molecules
Francesca Natale, Salvatore Fusco, Claudio Grassi
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 23
Dual Role of Exosome in Neurodegenerative Diseases: A Review Study
Mohsen Sheykhhasan, Fatemeh Heidari, Mohsen Eslami Farsani, et al.
Current Stem Cell Research & Therapy (2023) Vol. 19, Iss. 6, pp. 852-864
Closed Access | Times Cited: 14
Strategic nanocarriers to control neurodegenerative disorders: Concept, challenges, and future perspective
Sumel Ashique, Obaid Afzal, Sabina Yasmin, et al.
International Journal of Pharmaceutics (2023) Vol. 633, pp. 122614-122614
Closed Access | Times Cited: 13
A vivid outline demonstrating the benefits of exosome-mediated drug delivery in CNS-associated disease environments
Rachayeeta Ray, Sougata Ghosh Chowdhury, Parimal Karmakar
Archives of Biochemistry and Biophysics (2024) Vol. 753, pp. 109906-109906
Closed Access | Times Cited: 5
Extracellular Vesicles: The Next Generation of Biomarkers and Treatment for Central Nervous System Diseases
Gabriele Zanirati, Paula Gabrielli dos Santos, Allan Marinho Alcará, et al.
(2024)
Open Access | Times Cited: 5
Unveiling the role of exosomes as cellular messengers in neurodegenerative diseases and their potential therapeutic implications
Sumel Ashique, Nitish Kumar, Neeraj Mishra, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155451-155451
Closed Access | Times Cited: 5
Extracellular vesicles as biomarker and therapeutic targets for neurological disorders
Ufaq Razi, Faizan Ahmad, Anik Karan, et al.
Elsevier eBooks (2025), pp. 105-137
Closed Access
Intercellular communication via exosomes: A new paradigm in the pathophysiology of neurodegenerative disorders
Kiran S Satao, Gaurav Doshi
Life Sciences (2025) Vol. 365, pp. 123468-123468
Closed Access
Scouting Biomarkers for Alzheimer’s Disease via Network Analysis of Exosome Proteomics Data
Alexis Sagonas, Avgi E. Apostolakou, Zoi I. Litou, et al.
BioMedInformatics (2025) Vol. 5, Iss. 2, pp. 19-19
Open Access
Page 1 - Next Page

Scroll to top